Quadria Capital Invests $102M in NephroPlus, a Leading Dialysis Chain

• ByStartupStory     |    May 7, 2024

Hyderabad-based dialysis chain NephroPlus has secured Rs 850 crore ($102 million approximately) in funding from healthcare-focused private equity firm Quadria Capital. This investment represents a pivotal moment for NephroPlus, with Quadria Capital acquiring a substantial minority stake in the company through a combination of primary and secondary transactions.

The transaction, which involved the purchase of shares from existing stakeholders, is set to propel NephroPlus towards further expansion and market dominance. According to a statement released by NephroPlus, the capital infusion will be instrumental in supporting the company’s growth initiatives and strategic expansions, including potential acquisitions in the future.

Vikram Vuppala, Founder and CEO of NephroPlus, expressed optimism about the company’s trajectory, stating, “Our business has evolved tremendously over the past few years and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients.”

NephroPlus, founded in 2010 by Vikram Vuppala along with Kamal D Shah and Pullaiah Vuppala, has emerged as a formidable player in the dialysis sector, operating 450 dialysis centers across 250 towns and cities in India, Philippines, and Uzbekistan. Notably, the company has expanded its reach through strategic partnerships and acquisitions, including a joint venture with Saudi Arabia-based Tibbiyah aimed at bolstering its dialysis services.

Reflecting on the investment, Sunil Thakur, Partner and Head of South Asia at Quadria Capital, emphasized the firm’s commitment to supporting healthcare champions across Asia. “Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations,” Thakur remarked.

Avendus Capital played a pivotal role as the advisor to NephroPlus and its shareholders throughout the transaction, ensuring a successful partnership between NephroPlus and Quadria Capital.

Follow Startup Story